Evaluation of the Safety and Efficacy of Late-onset Pompe Disease Gene Therapy Drug

Clinical trial NCT06391736 · RECRUITING

Trial details

NCT number: NCT06391736
Sponsor: GeneCradle Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pompe Disease (Late-onset)

Start date: 2024-04-19
Primary completion: 2026-12-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.